Covestor LTD Invitae Corp Transaction History

Covestor LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$0.6 - $1.53 $16 - $41	27 Added 57.45%	74 $0
Q2 2023 Aug 11, 2023	SELL	$1.05 - $1.63 $1 - $1	-1 Reduced 2.08%	47 $0
Q4 2022 Feb 13, 2023	SELL	$1.71 - $3.61 $6 - $14	-4 Reduced 7.69%	48 $0
Q3 2022 Nov 14, 2022	BUY	$1.9 - $8.63 $20 - $94	11 Added 26.83%	52 $0
Q2 2022 Aug 10, 2022	BUY	$2.13 - $9.01 $12 - $54	6 Added 17.14%	41 $0
Q1 2022 May 13, 2022	SELL	$6.28 - $15.59 $1,243 - $3,086	-198 Reduced 84.98%	35 $0
Q4 2021 Feb 10, 2022	BUY	$14.7 - $28.67 $3,425 - $6,680	233 New	233 $4,000

1.92M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

Stay updated on Covestor LTD with notifications on news.